"Dermatologic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to treat or prevent skin disorders or for the routine care of skin.
| Descriptor ID |
D003879
|
| MeSH Number(s) |
D27.505.954.444
|
| Concept/Terms |
Dermatologic Agents- Dermatologic Agents
- Dermatological Agents
- Agents, Dermatological
- Agents, Dermatologic
- Dermatologic Agent
- Agent, Dermatologic
- Agent, Dermatological
- Dermatological Agent
|
Below are MeSH descriptors whose meaning is more general than "Dermatologic Agents".
Below are MeSH descriptors whose meaning is more specific than "Dermatologic Agents".
This graph shows the total number of publications written about "Dermatologic Agents" by people in this website by year, and whether "Dermatologic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2003 | 3 | 0 | 3 |
| 2005 | 1 | 2 | 3 |
| 2006 | 3 | 0 | 3 |
| 2007 | 1 | 0 | 1 |
| 2009 | 2 | 1 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 3 | 1 | 4 |
| 2014 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 3 | 3 |
| 2019 | 1 | 0 | 1 |
| 2020 | 3 | 0 | 3 |
| 2021 | 0 | 1 | 1 |
| 2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dermatologic Agents" by people in Profiles.
-
IL17A Blockade with Ixekizumab Suppresses MuvB Signaling in Clinical Psoriasis. J Invest Dermatol. 2023 09; 143(9):1689-1699.
-
Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1. Lancet Infect Dis. 2023 05; 23(5):525-526.
-
Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options. Am J Clin Dermatol. 2022 Jan; 23(1):37-50.
-
Ixekizumab in the treatment of moderate-to-severe plaque psoriasis: Patient adherence, satisfaction, and preferences. Dermatol Ther. 2021 01; 34(1):e14486.
-
Wound Healing and Wound Care in Neonates: Current Therapies and Novel Options. Adv Skin Wound Care. 2020 Jun; 33(6):294-300.
-
A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant Antagonist. J Med Chem. 2020 05 14; 63(9):4776-4789.
-
Ingenol Mebutate: Expanded Utility J Drugs Dermatol. 2020 Feb 1 j; 19(2):156-161.
-
Severe pretibial myxedema refractory to systemic immunosuppressants. Cutis. 2019 Sep; 104(3):E1-E3.
-
Retrospective case series of isotretinoin outcomes for acne in 393 female patients at Baylor College of Medicine during 2012-2016. J Am Acad Dermatol. 2020 05; 82(5):1218-1219.
-
Research priorities in childhood-onset lupus: results of a multidisciplinary prioritization exercise. Pediatr Rheumatol Online J. 2019 Jul 01; 17(1):32.